Frontiers in Molecular Neuroscience Molecular Neuroscience Review Article

Human startle disease, also known as hyperekplexia (OMIM 149400), is a paroxysmal neurological disorder caused by defects in glycinergic neurotransmission. Hyperekplexia is characterised by an exaggerated startle reflex in response to tactile or acoustic stimuli which first presents as neonatal hypertonia, followed in some with episodes of life-threatening infantile apnoea. Genetic screening studies have demonstrated that hyperekplexia is genetically heterogeneous with several missense and nonsense mutations in the postsynaptic glycine receptor (GlyR) α1 subunit gene (GLRA1) as the primary cause. More recently, missense, nonsense and frameshift mutations have also been identified in the glycine transporter GlyT2 gene, SLC6A5, demonstrating a presynaptic component to this disease. Further mutations, albeit rare, have been identified in the genes encoding the GlyR β subunit (GLRB), collybistin (ARHGEF9) and gephyrin (GPHN) – all of which are postsynaptic proteins involved in orchestrating glycinergic neurotransmission. In this review, we describe the clinical ascertainment aspects, phenotypic considerations and the downstream molecular genetic tools utilised to analyse both presynaptic and postsynaptic components of this heterogeneous human neurological disorder. Moreover, we will describe how the ancient startle response is the preserve of glycinergic neurotransmission and how animal models and human hyperekplexia patients have provided synergistic evidence that implicates this inhibitory system in the control of startle reflexes.

[1]  Hiromi Hirata,et al.  Defective Glycinergic Synaptic Transmission in Zebrafish Motility Mutants , 2009, Front. Mol. Neurosci..

[2]  M. Hiasa,et al.  Vesicular Inhibitory Amino Acid Transporter Is a Cl−/γ-Aminobutyrate Co-transporter* , 2009, The Journal of Biological Chemistry.

[3]  J. Meier,et al.  Splice‐specific roles of glycine receptor α3 in the hippocampus , 2009, The European journal of neuroscience.

[4]  Ronald W. Davis,et al.  High-throughput, high-accuracy array-based resequencing , 2009, Proceedings of the National Academy of Sciences.

[5]  J. Lynch,et al.  Native glycine receptor subtypes and their physiological roles , 2009, Neuropharmacology.

[6]  Reinhard Ullmann,et al.  A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation , 2009, Human mutation.

[7]  M. Duddy,et al.  Stiff person syndrome. , 2009, Frontiers of neurology and neuroscience.

[8]  S. El Mestikawy,et al.  The Orphan Transporter Rxt1/NTT4 (SLC6A17) Functions as a Synaptic Vesicle Amino Acid Transporter Selective for Proline, Glycine, Leucine, and Alanine , 2008, Molecular Pharmacology.

[9]  Michael K. Hutchinson,et al.  PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY , 2008, Neurology.

[10]  J. Rothberg,et al.  The development and impact of 454 sequencing , 2008, Nature Biotechnology.

[11]  M. Topf,et al.  The genetics of hyperekplexia: more than startle! , 2008, Trends in genetics : TIG.

[12]  J. Lupski,et al.  The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.

[13]  Kirsten Harvey,et al.  A Critical Role for Glycine Transporters in Hyperexcitability Disorders , 2008, Frontiers in molecular neuroscience.

[14]  H. Betz,et al.  The C-terminal PDZ-ligand motif of the neuronal glycine transporter GlyT2 is required for efficient synaptic localization , 2007, Molecular and Cellular Neuroscience.

[15]  J. Mayhew,et al.  Bilateral inguinal hernia repair in a child with hyperekplexia , 2007, Paediatric anaesthesia.

[16]  C. Schwartz,et al.  ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal , 2007, Journal of Medical Genetics.

[17]  C. Fertleman,et al.  Paroxysmal extreme pain disorder (previously familial rectal pain syndrome) , 2007, Neurology.

[18]  G. Bellenchi,et al.  The Transporters GlyT2 and VIAAT Cooperate to Determine the Vesicular Glycinergic Phenotype , 2007, The Journal of Neuroscience.

[19]  Robert Kleta,et al.  Crisponi syndrome is caused by mutations in the CRLF1 gene and is allelic to cold-induced sweating syndrome type 1. , 2007, American journal of human genetics.

[20]  A. Masri,et al.  Clinical and inheritance profiles of hyperekplexia in Jordan. , 2007, Journal of child neurology.

[21]  Michael Nilges,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btl655 Structural bioinformatics Biskit—A software platform for structural bioinformatics , 2006 .

[22]  V. Timmerman,et al.  Mutation scanning the GJB1 gene with high-resolution melting analysis: implications for mutation scanning of genes for Charcot-Marie-Tooth disease. , 2007, Clinical chemistry.

[23]  J. Ragoussis,et al.  Determination of the mutation spectrum of the EXT1/EXT2 genes in British Caucasian patients with multiple osteochondromas, and exclusion of six candidate genes in EXT negative cases , 2006, Human mutation.

[24]  C. Becker,et al.  Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. , 2006, Biochemical and biophysical research communications.

[25]  H. Meinck Startle and its disorders , 2006, Neurophysiologie Clinique/Clinical Neurophysiology.

[26]  M. Tijssen,et al.  Startle syndromes , 2009 .

[27]  Eric Gouaux,et al.  Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters , 2005, Nature.

[28]  M. Kneussel,et al.  Cellular localization and subcellular distribution of Unc‐33‐like protein 6, a brain‐specific protein of the collapsin response mediator protein family that interacts with the neuronal glycine transporter 2 , 2005, Journal of neurochemistry.

[29]  Hiromi Hirata,et al.  Zebrafish bandoneon mutants display behavioral defects due to a mutation in the glycine receptor beta-subunit. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Betz,et al.  Glycine transporters: essential regulators of neurotransmission. , 2005, Trends in biochemical sciences.

[31]  U. Heinemann,et al.  RNA editing produces glycine receptor α3P185L, resulting in high agonist potency , 2005, Nature Neuroscience.

[32]  Heinrich Betz,et al.  The β Subunit Determines the Ligand Binding Properties of Synaptic Glycine Receptors , 2005, Neuron.

[33]  U. Heinemann,et al.  RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency. , 2005, Nature neuroscience.

[34]  R. Morris,et al.  In vivo somatic delivery of plasmid DNA and retrograde transport to obtain cell‐specific gene expression in the central nervous system , 2004, Journal of neurochemistry.

[35]  H. Betz,et al.  The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1 , 2004, Molecular and Cellular Neuroscience.

[36]  E. Leshinsky‐Silver,et al.  Familial Hyperekplexia and Refractory Status Epilepticus: A New Autosomal Recessive Syndrome , 2004, Journal of child neurology.

[37]  M. Owen,et al.  The GDP-GTP Exchange Factor Collybistin: An Essential Determinant of Neuronal Gephyrin Clustering , 2004, The Journal of Neuroscience.

[38]  S. B. Caine,et al.  Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Y. Yanagawa,et al.  Gene structure and alternative splicing of the mouse glycine transporter type-2. , 2004, Biochemical and biophysical research communications.

[40]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[41]  D. Richter,et al.  Inactivation of the Glycine Transporter 1 Gene Discloses Vital Role of Glial Glycine Uptake in Glycinergic Inhibition , 2003, Neuron.

[42]  D. Richter,et al.  Deletion of the Mouse Glycine Transporter 2 Results in a Hyperekplexia Phenotype and Postnatal Lethality , 2003, Neuron.

[43]  M. Owen,et al.  Isoform Heterogeneity of the Human Gephyrin Gene (GPHN), Binding Domains to the Glycine Receptor, and Mutation Analysis in Hyperekplexia* , 2003, Journal of Biological Chemistry.

[44]  Marc A. Martí-Renom,et al.  Tools for comparative protein structure modeling and analysis , 2003, Nucleic Acids Res..

[45]  Jianning Wei,et al.  Demonstration of functional coupling between γ-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Owen,et al.  Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB). , 2002, Human molecular genetics.

[47]  S. Patole,et al.  Hyperekplexia in neonates , 2001, Postgraduate medical journal.

[48]  M. Owen,et al.  Compound heterozygosity and nonsense mutations in the α1-subunit of the inhibitory glycine receptor in hyperekplexia , 2001, Human Genetics.

[49]  J. Reiss,et al.  A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency. , 2001, American journal of human genetics.

[50]  D. Higgins,et al.  T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.

[51]  C. Becker,et al.  Autoimmunity to Gephyrin in Stiff-Man Syndrome , 2000, Neuron.

[52]  K. Osen,et al.  The Vesicular GABA Transporter, VGAT, Localizes to Synaptic Vesicles in Sets of Glycinergic as Well as GABAergic Neurons , 1998, The Journal of Neuroscience.

[53]  C. Giménez,et al.  Characterization of the 5′ region of the rat brain glycine transporter GLYT2 gene: identification of a novel isoform , 1998, Neuroscience Letters.

[54]  D A Kane,et al.  Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. , 1996, Development.

[55]  G. Crisponi Autosomal recessive disorder with muscle contractions resembling neonatal tetanus, characteristic face, camptodactyly, hyperthermia, and sudden death: a new syndrome? , 1996, American journal of medical genetics.

[56]  P. O’Connell,et al.  Mutational analysis of familial and sporadic hyperekplexia , 1995, Annals of neurology.

[57]  L. Shield,et al.  Hyperekplexia as cause of abnormal intrauterine movements , 1995, The Lancet.

[58]  M. Owen,et al.  Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor. , 1994, Human molecular genetics.

[59]  W. White,et al.  A frameshift mutation in the mouse alpha 1 glycine receptor gene (Glra1) results in progressive neurological symptoms and juvenile death. , 1994, Human molecular genetics.

[60]  M. Fischer,et al.  The spastic mouse: Aberrant splicing of glycine receptor β subunit mRNA caused by intronic insertion of Ll element , 1994, Neuron.

[61]  R. Bartholomew Disease, Disorder, or Deception? Latah as Habit in a Malay Extended Family , 1994, The Journal of nervous and mental disease.

[62]  P. O'Connell,et al.  A missense mutation in the gene encoding the α1 subunit of the inhibitory glycine receptor in the spasmodic mouse , 1994, Nature Genetics.

[63]  S. Kingsmore,et al.  Glycine receptor β–subunit gene mutation in spastic mouse associated with LINE–1 element insertion , 1994, Nature Genetics.

[64]  G. Giacoia,et al.  Hyperekplexia associated with apnea and sudden infant death syndrome. , 1994, Archives of pediatrics & adolescent medicine.

[65]  P. O'Connell,et al.  Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia , 1993, Nature Genetics.

[66]  N. Nelson,et al.  A rat brain cDNA encoding the neurotransmitter transporter with an unusual structure , 1993, FEBS letters.

[67]  C. Becker,et al.  Isoform-selective deficit of glycine receptors in the mouse mutant spastic , 1992, Neuron.

[68]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[69]  B. Bernardina,et al.  STARTLE DISEASE: AN AVOIDABLE CAUSE OF SUDDEN INFANT DEATH , 1989, The Lancet.

[70]  F. Andermann,et al.  Startle disease or hyperekplexia: further delineation of the syndrome. , 1980, Brain : a journal of neurology.

[71]  M. K. el-Din A familial convulsive disorder with an unusual onset during intrauterine life: a case report. , 1960, The Journal of pediatrics.

[72]  L. Kirstein,et al.  A FAMILY WITH EMOTIONALLY PRECIPITATEED “DROP SEIZURES” , 1958 .

[73]  L. Kirstein,et al.  A family with emotionally precipitated drop seizures. , 1958, Acta psychiatrica et neurologica Scandinavica.